chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Chills, Oxygen saturation
Clinical narrative: Elevated temperature of 99.3°F; Oxygen saturation level 91%; Chills; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE INCREASED (Elevated temperature of 99.3°F), OXYGEN SATURATION (Oxygen saturation level 91%) and CHILLS (Chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 043L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included CALCIUM CARBONATE, CALCIUM CITRATE, COLECALCIFEROL (CITRACAL SLOW RELEASE 1200) for Bone pain, SIMVASTATIN for High cholesterol, LEVOTHYROXINE for Hypothyroidism, VITAMIN D3 and WOMEN'S DAILY for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced BODY TEMPERATURE INCREASED (Elevated temperature of 99.3°F), OXYGEN SATURATION (Oxygen saturation level 91%) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 27-Feb-2021, BODY TEMPERATURE INCREASED (Elevated temperature of 99.3°F), OXYGEN SATURATION (Oxygen saturation level 91%) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 99.3 Farad High. On 26-Feb-2021, Oxygen saturation: 91 % abnormal.         On Friday 26Feb2021 on the afternoon and evening patient had elevated temperature of 99.3°F at 4pm.  Took one Tylenol at 3pm and another that night  Recently added concomitant medications.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Patient information added.concomitants added (Levothyroxin , Simvastatin ,Citracal slow release, Vitamin D3 ,One a Day women's 50 plus)
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 01-Feb-2021 at 9:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). At the time of the report, PAIN IN EXTREMITY (arm was sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable..   This case was linked to US-MODERNATX, INC.-MOD-2021-029880, US-MODERNATX, INC.-MOD-2021-029880 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-029880:Husband case US-MODERNATX, INC.-MOD-2021-029880:Husband case
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; A spontaneous report (United States) was received from a consumer concerning herself, a female patient, of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event fever.  The patient's medical history included knee surgery and was having trouble to walk. Concomitant medication use was not provided by reporter.   On an 25-Feb-2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Batch number unknown ) intramuscularly for COVID-19 infection prophylaxis.   On 25/Feb/2021, after second dose of the Moderna vaccine, the patient experienced event fever.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event fever was considered to be resolved at the time of this report.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Myalgia, Pain in extremity
Clinical narrative: Painful to lift arms above the head; Joint pain; Fatigue; Muscle pain; Low grade fever of 98.1; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful to lift arms above the head), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle pain) and PYREXIA (Low grade fever of 98.1) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Painful to lift arms above the head), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle pain) and PYREXIA (Low grade fever of 98.1). At the time of the report, PAIN IN EXTREMITY (Painful to lift arms above the head), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle pain) and PYREXIA (Low grade fever of 98.1) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 98.1 (Inconclusive) 98.1.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Painful to lift arms above the head; Joint pain; Fatigue; Muscle pain; Low grade fever of 98.1; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful to lift arms above the head), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle pain) and PYREXIA (Low grade fever of 98.1) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Painful to lift arms above the head), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle pain) and PYREXIA (Low grade fever of 98.1). At the time of the report, PAIN IN EXTREMITY (Painful to lift arms above the head), ARTHRALGIA (Joint pain), FATIGUE (Fatigue), MYALGIA (Muscle pain) and PYREXIA (Low grade fever of 98.1) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 98.1 (Inconclusive) 98.1.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Severe unusual headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe unusual headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Severe unusual headache). At the time of the report, HEADACHE (Severe unusual headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported.  Treatment details not reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Hands, arms and legs are itchy; Rash is mainly where touched/scratched - mostly arms, hands, and inside of thighs, its is on most of his legs, as well; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Hands, arms and legs are itchy) and RASH (Rash is mainly where touched/scratched - mostly arms, hands, and inside of thighs, its is on most of his legs, as well) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011821A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL), APIXABAN (ELIQUIS), ATORVASTATIN CALCIUM (LIPITOR), METOPROLOL TARTRATE (LOPRESSOR), VENLAFAXINE, PALIVIZUMAB and VITAMINS NOS (MULTIPLE VITAMIN) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PRURITUS (Hands, arms and legs are itchy) and RASH (Rash is mainly where touched/scratched - mostly arms, hands, and inside of thighs, its is on most of his legs, as well). At the time of the report, PRURITUS (Hands, arms and legs are itchy) and RASH (Rash is mainly where touched/scratched - mostly arms, hands, and inside of thighs, its is on most of his legs, as well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications includes Benadryl and some lotion.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: joint pain in the right elbow; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain in the right elbow) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A71A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure since an unknown date and Cholesterol since an unknown date. Concomitant products included ACETYLSALICYLIC ACID (ASPRIN) and MULTIVITAMINS & MINERALS PLUS LUTEIN for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced ARTHRALGIA (joint pain in the right elbow). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 2. At the time of the report, ARTHRALGIA (joint pain in the right elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medications for blood pressure, cholesterol, multivitamin and baby aspirin
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling, Vaccination site warmth
Clinical narrative: COVID arm; warm to the touch at the injection site; red and itchy area around the injection site; swollen area at the injection site; red and itchy area around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm), VACCINATION SITE WARMTH (warm to the touch at the injection site), VACCINATION SITE PRURITUS (red and itchy area around the injection site), VACCINATION SITE SWELLING (swollen area at the injection site) and VACCINATION SITE ERYTHEMA (red and itchy area around the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Milk allergy (soy milk ) and Drug allergy. Concomitant products included CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM + VIT D) and ASCORBIC ACID, CUPRIC OXIDE, DL-ALPHA TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC OXIDE (PRESERVISION AREDS 2) for Routine health maintenance, CENTRUM SILVER WOMEN 50+ for Vitamin supplementation, ATORVASTATIN for an unknown indication.    On 20-Feb-2021 at 3:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (red and itchy area around the injection site), VACCINATION SITE SWELLING (swollen area at the injection site) and VACCINATION SITE ERYTHEMA (red and itchy area around the injection site). On 27-Feb-2021 at 7:00 PM, the patient experienced VACCINATION SITE REACTION (COVID arm) and VACCINATION SITE WARMTH (warm to the touch at the injection site). On 09-Mar-2021, VACCINATION SITE REACTION (COVID arm), VACCINATION SITE WARMTH (warm to the touch at the injection site), VACCINATION SITE PRURITUS (red and itchy area around the injection site), VACCINATION SITE SWELLING (swollen area at the injection site) and VACCINATION SITE ERYTHEMA (red and itchy area around the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided.  The size of the reaction was rectangular shaped about 3 1/2 inches by 2 1/2 inches.   This case was linked to MOD-2021-107632 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Updated patient demographics, patient medical history, suspect product details, concomitant medications and events On 14-Jul-2021: contains No New Information.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Post-traumatic neck syndrome, Vaccination site bruising
Clinical narrative: whiplash; Injection site bruises; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Injection site bruises) and POST-TRAUMATIC NECK SYNDROME (whiplash) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE BRUISING (Injection site bruises). On an unknown date, the patient experienced POST-TRAUMATIC NECK SYNDROME (whiplash). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE BRUISING (Injection site bruises) and POST-TRAUMATIC NECK SYNDROME (whiplash) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea
Clinical narrative: diarrhea; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.No relevant concomitant medications were reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced DIARRHOEA (diarrhea) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea) and CHILLS (chills) outcome was unknown.       No treatment information was provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pruritus, Vaccination site rash
Clinical narrative: itchy rash 2 inches below the injection site; itchiness at injection site; felt unusually tired; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (felt unusually tired), VACCINATION SITE RASH (itchy rash 2 inches below the injection site) and VACCINATION SITE PRURITUS (itchiness at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced FATIGUE (felt unusually tired) and VACCINATION SITE PRURITUS (itchiness at injection site). On 08-Feb-2021, the patient experienced VACCINATION SITE RASH (itchy rash 2 inches below the injection site). On 08-Feb-2021, FATIGUE (felt unusually tired) had resolved. At the time of the report, VACCINATION SITE RASH (itchy rash 2 inches below the injection site) and VACCINATION SITE PRURITUS (itchiness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included acetaminophen for the unusual tiredness and Tylenol   Concomitant medications were not provided.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Vaccination site pain
Clinical narrative: Shoulder pain ( L arm, injection site); The first night he couldn't sleep; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (The first night he couldn't sleep) and VACCINATION SITE PAIN (Shoulder pain ( L arm, injection site)) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced INSOMNIA (The first night he couldn't sleep). On an unknown date, the patient experienced VACCINATION SITE PAIN (Shoulder pain ( L arm, injection site)). At the time of the report, INSOMNIA (The first night he couldn't sleep) and VACCINATION SITE PAIN (Shoulder pain ( L arm, injection site)) outcome was unknown.            Concomitant information  was Type 2 diabetes medicine.  Treatment information was not provided   This case was linked to MOD-2021-032275 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received and contain non significant information.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Throat irritation
Clinical narrative: itchy/dry throat; Feverish; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (itchy/dry throat) and PYREXIA (Feverish) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concomitant products included Anti Depressant and Cholesterol Medication for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THROAT IRRITATION (itchy/dry throat) and PYREXIA (Feverish). At the time of the report, THROAT IRRITATION (itchy/dry throat) and PYREXIA (Feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: red circle the size of a "half dollar"; it itches like crazy; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (red circle the size of a "half dollar") and VACCINATION SITE PRURITUS (it itches like crazy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness). On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red circle the size of a "half dollar") and VACCINATION SITE PRURITUS (it itches like crazy). At the time of the report, VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (red circle the size of a "half dollar") and VACCINATION SITE PRURITUS (it itches like crazy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: "really bad rash" at the injection site; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of INJECTION SITE RASH ("really bad rash" at the injection site) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 01-Mar-2021, the patient experienced INJECTION SITE RASH ("really bad rash" at the injection site). At the time of the report, INJECTION SITE RASH ("really bad rash" at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information use was not reported.  Treatment information was not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: appetite decreased, very unusual; very little soreness around the area of injection; not motivated to do anything; temperature 96.6°F (usually little lower); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (appetite decreased, very unusual), VACCINATION SITE PAIN (very little soreness around the area of injection), FATIGUE (not motivated to do anything) and PYREXIA (temperature 96.6°F (usually little lower)) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 016M20A) for COVID-19 vaccination.     Concomitant products included VITAMIN D NOS, CALCIUM and MULTIVITAMIN & MINERAL for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced PYREXIA (temperature 96.6°F (usually little lower)). On an unknown date, the patient experienced DECREASED APPETITE (appetite decreased, very unusual), VACCINATION SITE PAIN (very little soreness around the area of injection) and FATIGUE (not motivated to do anything). At the time of the report, DECREASED APPETITE (appetite decreased, very unusual), VACCINATION SITE PAIN (very little soreness around the area of injection), FATIGUE (not motivated to do anything) and PYREXIA (temperature 96.6°F (usually little lower)) outcome was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Pruritus
Clinical narrative: arm was red; sore arm; itchy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm was red), PAIN IN EXTREMITY (sore arm) and PRURITUS (itchy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (arm was red), PAIN IN EXTREMITY (sore arm) and PRURITUS (itchy). At the time of the report, ERYTHEMA (arm was red), PAIN IN EXTREMITY (sore arm) and PRURITUS (itchy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: sleepiness; Fatigue that comes and goes; This spontaneous case was reported by a physician and describes the occurrence of SOMNOLENCE (sleepiness) and FATIGUE (Fatigue that comes and goes) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical history was reported.  Concomitant products included LORATADINE for Allergy, ALPRAZOLAM for Sleep problem, PANTOPRAZOLE and ESCITALOPRAM for an unknown indication.    On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced FATIGUE (Fatigue that comes and goes). On an unknown date, the patient experienced SOMNOLENCE (sleepiness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (sleepiness) and FATIGUE (Fatigue that comes and goes) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reported fatigue has come back in full force. It is Friday, Saturday, Sunday, today (understood as 01-Mar-2021) she was feeling a little better.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Herpes zoster
Clinical narrative: think it's shingles; I saw couple of spot under my breast, did not think its shingles but than saw NP on; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (I saw couple of spot under my breast, did not think its shingles but than saw NP on) and HERPES ZOSTER (think it's shingles) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], ATORVASTATIN, METOPROLOL SUCCINATE, FAMOTIDINE (PEPCID [FAMOTIDINE]) and PROPAFENONE for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced ADVERSE REACTION (I saw couple of spot under my breast, did not think its shingles but than saw NP on). On 08-Feb-2021, the patient experienced HERPES ZOSTER (think it's shingles). The patient was treated with BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORIN [BACITRACIN;NEOMYCIN SULFATE;POLYMYXIN B SULFATE]) at an unspecified dose and frequency and VALACYCLOVIR [VALACICLOVIR] at an unspecified dose and frequency. At the time of the report, ADVERSE REACTION (I saw couple of spot under my breast, did not think its shingles but than saw NP on) and HERPES ZOSTER (think it's shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Nervousness
Clinical narrative: nervous; Feeling nauseous; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (nervous) and NAUSEA (Feeling nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced NERVOUSNESS (nervous) and NAUSEA (Feeling nauseous). At the time of the report, NERVOUSNESS (nervous) and NAUSEA (Feeling nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Rhinorrhoea
Clinical narrative: cough; runny nose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough) and RHINORRHOEA (runny nose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced COUGH (cough) and RHINORRHOEA (runny nose). At the time of the report, COUGH (cough) and RHINORRHOEA (runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site swelling
Clinical narrative: Site of injection is red and swollen; site of injection become blue and black; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Site of injection is red and swollen) and VACCINATION SITE DISCOLOURATION (site of injection become blue and black) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Site of injection is red and swollen) and VACCINATION SITE DISCOLOURATION (site of injection become blue and black). At the time of the report, VACCINATION SITE SWELLING (Site of injection is red and swollen) and VACCINATION SITE DISCOLOURATION (site of injection become blue and black) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Asthenia, Pain, Pyrexia
Clinical narrative: loss of taste; weakness; soreness; fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (loss of taste), ASTHENIA (weakness), PAIN (soreness) and PYREXIA (fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (loss of taste), ASTHENIA (weakness), PAIN (soreness) and PYREXIA (fever). At the time of the report, AGEUSIA (loss of taste), ASTHENIA (weakness), PAIN (soreness) and PYREXIA (fever) outcome was unknown.            Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Redness; Itchiness; Rash; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), PRURITUS (Itchiness) and RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness), PRURITUS (Itchiness) and RASH (Rash). At the time of the report, ERYTHEMA (Redness), PRURITUS (Itchiness) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported  No treatment medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Reporter details updated, patient details updated
Sex: F
Vaccine: COVID19
Symptoms: Cough, Influenza like illness
Clinical narrative: flu-like symptoms such as cough but no fever; flu-like symptoms such as cough but no fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms such as cough but no fever) and COUGH (flu-like symptoms such as cough but no fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms such as cough but no fever) and COUGH (flu-like symptoms such as cough but no fever). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms such as cough but no fever) and COUGH (flu-like symptoms such as cough but no fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information use was not reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: Had to stay in bed all day; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Had to stay in bed all day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ASTHENIA (Had to stay in bed all day). On 26-Feb-2021, ASTHENIA (Had to stay in bed all day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pain, Peripheral swelling, Pyrexia
Clinical narrative: swollen arm; dizziness; body aches; major headaches; fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), DIZZINESS (dizziness), PAIN (body aches), HEADACHE (major headaches) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm), DIZZINESS (dizziness), PAIN (body aches), HEADACHE (major headaches) and PYREXIA (fever). At the time of the report, PERIPHERAL SWELLING (swollen arm), DIZZINESS (dizziness), PAIN (body aches), HEADACHE (major headaches) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fear, Feeling abnormal, Inappropriate affect
Clinical narrative: Felt like she could not move her arm; Had no power in her arms and could hardly hold a teacup; Started feeling funny; Was frightened; Not much of an appetite and did not want to eat; Not feeling 100%; Had chills; The shot was very painful and she felt like it was going to go through her arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Felt like she could not move her arm), MUSCULAR WEAKNESS (Had no power in her arms and could hardly hold a teacup), INAPPROPRIATE AFFECT (Started feeling funny), FEAR (Was frightened) and DECREASED APPETITE (Not much of an appetite and did not want to eat) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Felt like she could not move her arm), MUSCULAR WEAKNESS (Had no power in her arms and could hardly hold a teacup), INAPPROPRIATE AFFECT (Started feeling funny), FEAR (Was frightened), DECREASED APPETITE (Not much of an appetite and did not want to eat), FEELING ABNORMAL (Not feeling 100%), CHILLS (Had chills) and VACCINATION SITE PAIN (The shot was very painful and she felt like it was going to go through her arm). On 26-Feb-2021, PAIN IN EXTREMITY (Felt like she could not move her arm), MUSCULAR WEAKNESS (Had no power in her arms and could hardly hold a teacup), INAPPROPRIATE AFFECT (Started feeling funny), FEAR (Was frightened), DECREASED APPETITE (Not much of an appetite and did not want to eat), FEELING ABNORMAL (Not feeling 100%), CHILLS (Had chills) and VACCINATION SITE PAIN (The shot was very painful and she felt like it was going to go through her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain in extremity, Vaccination site pain
Clinical narrative: Felt like she could not move her arm; Had no power in her arms and could hardly hold a teacup; Started feeling funny; Was frightened; Not much of an appetite and did not want to eat; Not feeling 100%; Had chills; The shot was very painful and she felt like it was going to go through her arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Felt like she could not move her arm), MUSCULAR WEAKNESS (Had no power in her arms and could hardly hold a teacup), INAPPROPRIATE AFFECT (Started feeling funny), FEAR (Was frightened) and DECREASED APPETITE (Not much of an appetite and did not want to eat) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Felt like she could not move her arm), MUSCULAR WEAKNESS (Had no power in her arms and could hardly hold a teacup), INAPPROPRIATE AFFECT (Started feeling funny), FEAR (Was frightened), DECREASED APPETITE (Not much of an appetite and did not want to eat), FEELING ABNORMAL (Not feeling 100%), CHILLS (Had chills) and VACCINATION SITE PAIN (The shot was very painful and she felt like it was going to go through her arm). On 26-Feb-2021, PAIN IN EXTREMITY (Felt like she could not move her arm), MUSCULAR WEAKNESS (Had no power in her arms and could hardly hold a teacup), INAPPROPRIATE AFFECT (Started feeling funny), FEAR (Was frightened), DECREASED APPETITE (Not much of an appetite and did not want to eat), FEELING ABNORMAL (Not feeling 100%), CHILLS (Had chills) and VACCINATION SITE PAIN (The shot was very painful and she felt like it was going to go through her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: injection site itching; Site of injection has red mark; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE ERYTHEMA (Site of injection has red mark) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE ERYTHEMA (Site of injection has red mark). At the time of the report, VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE ERYTHEMA (Site of injection has red mark) outcome was unknown.            Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Pain in extremity
Clinical narrative: Pain on her left breast down near her armpit, which spread around her breast; Arm hurt for 24 hours; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt for 24 hours) and BREAST PAIN (Pain on her left breast down near her armpit, which spread around her breast) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt for 24 hours). On an unknown date, the patient experienced BREAST PAIN (Pain on her left breast down near her armpit, which spread around her breast). On 25-Feb-2021, PAIN IN EXTREMITY (Arm hurt for 24 hours) had resolved. At the time of the report, BREAST PAIN (Pain on her left breast down near her armpit, which spread around her breast) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Swelling face
Clinical narrative: lip swelling; Facial swelling made me look like a chipmunk; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lip swelling) and SWELLING FACE (Facial swelling made me look like a chipmunk) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced LIP SWELLING (lip swelling) and SWELLING FACE (Facial swelling made me look like a chipmunk). On 08-Feb-2021, LIP SWELLING (lip swelling) and SWELLING FACE (Facial swelling made me look like a chipmunk) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications and No Treatment medications were reported. Patient states no derma fillers taken.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Updated Reporter details[Address, Email and Fax].
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at the injection site/at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site/at the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site/at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site/at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Felt tired for one day; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt tired for one day) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 24M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included FINASTERIDE, DULOXETINE, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ) and AMLODIPINE for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced FATIGUE (Felt tired for one day). At the time of the report, FATIGUE (Felt tired for one day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.